Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
> www.clinicaltrials.gov Once you are on the website, type “NCT02917031”
into the search box and click “Search”.
> http://www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2015-004825-14” in the search box and click “Search”.
> www.AstraZenecaClinicalTrials.com Once you are on the website, type “D1680C00016”
into the search box, and click “Find a Study”.
Full Study Title: MEchAniStic evalUation of glucose-loweRing strategiEs in patients with Heart
Failure (MEASURE-HF). A 24-Week, Multicenter, Randomised, Double-blind, Parallel Group,
Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients with
Type 2 Diabetes Mellitus and Heart Failure
AstraZeneca AB Protocol Number: D1680C00016
National Clinical Trials number: NCT02917031
EudraCT number: 2015-004825-14
AstraZeneca AB sponsored this study and has its headquarters at Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants and their families belong to a large community of people who take
part in clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2021_06_09
12 | Clinical Study Results